Over the past five trading sessions, select smallcap stocks posted gains of up to 27%. Fermenta Biotech led with a 26% rise, followed by Stallion India Fluorochemicals and Rolex Rings. Sectors such as niche pharma, specialty chemicals, auto components, media, IT, and infrastructure witnessed renewed investor interest. The rally highlights heightened volatility, speculative activity, and rapid price discovery in smaller companies.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026